• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » GE HealthCare launches new AI-powered cardiovascular ultrasound system

GE HealthCare launches new AI-powered cardiovascular ultrasound system

August 29, 2025 By Sean Whooley

GE HealthCare Vivid Pioneer 2
The Vivid Pioneer cardiovascular ultrasound system. [Image courtesy of GE HealthCare]

GE HealthCare (Nasdaq: GEHC) today announced the launch of Vivid Pioneer, its newest, most advanced cardiovascular ultrasound system.

The company built Vivid Pioneer on its existing Vivid platform, but completely redesigned this latest generation. It supports clinicians with imaging in 2D, 4D and color flow, along with streamlined workflows and enhanced diagnostic confidence.

GE HealthCare recently received both CE mark and FDA 510(k) clearance for the system. It has Vivid Pioneer on display at the European Society of Cardiology (ESC) Congress 2025 in Madrid, along with other cardiology innovations.

Vivid Pioneer, powered by the next-generation cSound Pioneer architecture and probe technology, offers sharp, detailed cardiac imaging. It produces enhanced spatial and contrast resolution, improved color sensitivity and 4D imaging. The system’s 4Vc-D and new 6Sc-D proves, built on XDclear technology, enable the visualization of fine anatomical structures. These probes enable the assessment of cardiac function with improved accuracy across a range of patients, from pediatrics to adults.

GE HealthCare said that Vivid Pioneer also offers 360% faster AI performance. It utilizes AI to reduce inter-operator variability and accelerate workflows. Additionally, it has an ergonomic design with a simplified user interface, larger screen and customizable touch panel. Its onboard battery enables uninterrupted workflow when moving the compact form factor from room to room.

“Vivid Pioneer is built to meet the moment in cardiovascular care where precision, speed, and accuracy are essential,” said Jyoti Gera, CEO, CardioVascular and Interventional Solutions, Advanced Visualization Solutions at GE HealthCare. “With its next-generation imaging engine, AI-powered automation, and intuitive design, the goal of Vivid Pioneer is to empower clinicians to see more, do more, and address patient needs with comfort and confidence.”

Filed Under: Artificial Intelligence (AI), Cardiovascular, Health Technology, Imaging, Machine Learning (ML), Software / IT, Ultrasound Tagged With: ESC 2025, GE Healthcare

More recent news

  • Former Shockwave Medical CEO joins Solenic Medical’s board
  • Anaconda Biomed brings in $56 million
  • Precision Neuroscience raises $250M in Series D for its BCI
  • Fresenius discontinuing Chinese sales of 4008A hemodialysis system
  • Perfuze’s super-bore stroke catheter tops conventional, cyclic aspiration in bench study

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy